NCT00252343View on ClinicalTrials.gov

Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Anxiety Disorder
Interventions
DRUG

SR58611A

Trial Locations (1)

08807

Sanofi-Aventis Administrative Office, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00252343 - Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety Disorder | Biotech Hunter | Biotech Hunter